Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
CRANBURY, N.J., Nov. 16, 2010 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN) today announced the appointment of Jeffrey D. Edelson, M.D., as Chief Medical Officer. Dr. Edelson has more than 15 years of leadership experience in the successful clinical development of medicines for the pharmaceutical and biotechnology industries. Dr. Edelson has been responsible for …
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer Read More »